Preparation of PEGylated Liposomal Ginsenoside; Formulation Design and in vitro Evaluation-论文-万方医学网

Preparation of PEGylated Liposomal Ginsenoside; Formulation Design and in vitro Evaluation

导出原文传递

翻译打印收藏纠错

作者： Cui, Y. Q. ^[1] ; Yang, P. ^[2] ; Sun, P. ^[3] ; Yan, Y. D. ^[4] ; Jin, G. Y. ^[5] ; Quan, J. S.

作者单位： Yanbian Univ Hosp,Yanbian Univ Hosp, Dept Radiol, Jilin 133000, Jilin, Peoples R China ^[1] Yanbian Univ Hosp,Yanbian Univ Hosp, Dept Pharm, Jilin 133000, Jilin, Peoples R China ^[2] Yanbian Univ Hosp,Yanbian Univ Hosp, Antu Cty Hlth Supervis Inst, Jilin 133000, Jilin, Peoples R ^[3] Yanbian Univ,Yanbian Univ, Coll Pharm, Dept Pharmaceut, Jilin 133000, Jilin, Peoples R China ^[4] Beijing Fogangren Biopharma Ltd,Beijing Fogangren Biopharma Ltd, Beijing 102628, Peoples R China ^[5]

关键词 Ginsenoside Rg3 PEGylated liposomes Box-Behnken design PHASE-TRANSITION TEMPERATURE DRUG-DELIVERY RG3 OPTIMIZATION CANCER VIVO PHOSPHOLIPIDS DOXORUBICIN INHIBITION STABILITY

发布时间 2022-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除